Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $449.0M |
| Sales growthchange from the year before | -5.3% |
| Gross marginshare of sales left after the direct cost of what it sells | 89.2% |
| Operating marginshare of sales left after running the business | -4.3% |
| Net marginshare of sales kept as profit | -7.3% |
| Free-cash-flow marginspare cash generated per $100 of sales | 2.2% |
| Return on equityprofit vs. shareholders' accounting value | n/m |
| Debt / equitydebt vs. shareholders' accounting value | n/m |
| Change in share countnegative = the company is buying back its shares | -8.8% |
2 insiders sold $45K (all under pre-arranged plans) on the open market.
| Sakamoto Ryan T.EVP, Chief Legal Officer | Sold (plan)Jul 24 | 3,547 shat $3.91 · $14K |
| Garefis AmyEVP, Chief People Officer | Sold (plan)Jul 20 | 7,983 shat $3.95 · $32K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy